当前位置:首页 - 行情中心 - 华兰疫苗(301207) - 财务分析

华兰疫苗

(301207)

  

流通市值:113.28亿  总市值:113.35亿
流通股本:6.01亿   总股本:6.01亿

华兰疫苗(301207)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.32亿元,每股收益0.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益567484.16万元,未分配利润194859.38万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产717936.97万元,负债150452.81万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入805,986,896.8459,961,774.2724,282,534.721,127,812,323.85
营业总成本757,546,402.98163,447,081.2349,573,022.32961,283,918.27
其他经营收益
营业利润139,351,616.4812,130,347.3936,468,293.21214,856,027.17
利润总额137,628,010.9111,201,943.9435,337,733.22214,545,726.25
净利润132,308,600.0520,797,156.832,777,072.14205,515,315.75
每股收益
其他综合收益----
综合收益总额132,308,600.0520,797,156.832,777,072.14205,515,315.75
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计4,780,080,177.714,469,705,467.845,058,482,095.794,976,519,526.9
非流动资产:
非流动资产合计2,399,289,543.022,442,690,269.552,384,676,612.062,546,736,316.68
资产总计7,179,369,720.736,912,395,737.397,443,158,707.857,523,255,843.58
流动负债:
流动负债合计1,464,360,450.82949,798,339.251,352,185,166.851,464,122,765.1
非流动负债:
非流动负债合计40,167,626.4144,063,360.7443,255,764.3145,988,556.58
负债合计1,504,528,077.23993,861,699.991,395,440,931.161,510,111,321.68
所有者权益(或股东权益):
归属于母公司股东权益合计5,674,841,643.55,918,534,037.46,047,717,776.696,013,144,521.9
股东权益合计5,674,841,643.55,918,534,037.46,047,717,776.696,013,144,521.9
负债和股东权益合计7,179,369,720.736,912,395,737.397,443,158,707.857,523,255,843.58
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计865,490,687.86557,752,953.21224,237,741.751,832,965,932.34
经营活动现金流出小计683,526,569.61451,974,780.09226,825,367.561,364,924,489.86
经营活动产生的现金流量净额181,964,118.25105,778,173.12-2,587,625.81468,041,442.48
投资活动产生的现金流量:
投资活动现金流入小计6,262,680,030.875,201,373,034.063,485,674,379.619,428,608,927.27
投资活动现金流出小计5,773,605,406.134,988,858,844.993,585,330,704.9819,489,688,786.19
投资活动产生的现金流量净额489,074,624.74212,514,189.07-99,656,325.38-61,079,858.92
筹资活动产生的现金流量:
筹资活动现金流入小计---16,281,000
筹资活动现金流出小计440,093,339.95359,093,339.9530,660,000.01441,103,352.53
筹资活动产生的现金流量净额-440,093,339.95-359,093,339.95-30,660,000.01-424,822,352.53
汇率变动对现金及现金等价物的影响155,717.47170,007.4255,928.01-84,323.07
现金及现金等价物净增加额231,101,120.51-40,630,970.34-132,848,023.19-17,945,092.04
期末现金及现金等价物余额854,136,140.42582,404,049.57490,186,996.72623,035,019.91
补充资料:
现金及现金等价物的净增加额--40,630,970.34--17,945,092.04
TOP↑